MicroRNAs (miRNAs) play essential, conserved roles in diverse developmental processes through association with the miRNAinduced silencing complex (miRISC). Whereas fundamental insights into the mechanistic framework of miRNA biogenesis and target gene silencing have been established, posttranslational modifications that affect miRISC function are less well understood. Here we report that the conserved serine/threonine kinase, casein kinase II (CK2), promotes miRISC function in Caenorhabditis elegans. CK2 inactivation results in developmental defects that phenocopy loss of miRISC cofactors and enhances the loss of miRNA function in diverse cellular contexts. Whereas CK2 is dispensable for miRNA biogenesis and the stability of miRISC cofactors, it is required for efficient miRISC target mRNA binding and silencing. Importantly, we identify the conserved DEAD-box RNA helicase, CGH-1/DDX6, as a key CK2 substrate within miRISC and demonstrate phosphorylation of a conserved N-terminal serine is required for CGH-1 function in the miRNA pathway.
microRNA | casein kinase II | phosphorylation | miRISC | CGH-1 S ince the discovery of lin-4 and let-7 in Caenorhabditis elegans, microRNAs (miRNAs) have emerged as an evolutionarily conserved superfamily of small endogenous RNAs critical for posttranscriptional gene regulation (1, 2) . miRNAs regulate diverse biological processes including animal development, cell differentiation, apoptosis, and metabolism (1) (2) (3) . To date, at least 250 miRNAs have been identified in C. elegans and almost 10 times as many in human (4) . Furthermore, miRNAs are predicted to target as much as half of the transcriptome, further underscoring their central role in posttranscriptional gene silencing mechanisms (5) . miRNAs are typically transcribed as long primary transcripts that are processed sequentially by the RNase III enzymes Drosha and Dicer to produce an ∼70-nt precursor hairpin and an ∼22-nt RNA duplex, respectively (6, 7) . One strand of the duplex is selectively loaded as the mature miRNA into an Argonaute (Ago) family protein that forms the core of miRNA-induced silencing complex (miRISC) in conjunction with a GW182 family protein (6, 7) . Partial base pairing of the miRNA with complementary sites predominantly located in the 3′UTR of target mRNAs leads to transcript destabilization, translational repression, or both (3, 8) .
Through a combination of genetic and biochemical approaches, conserved miRISC factors have been identified in C. elegans, including Argonaute-like genes ALG-1 and ALG-2, orthologs of human Ago2 (9) . Mutation of alg-1 results in pleiotropic phenotypes, consistent with loss of miRNA regulation in diverse biological pathways (9, 10) . In contrast, alg-2 mutants are superficially wild type, suggesting a partially redundant role in miRNA-mediated processes (10) . ALG-1 physically interacts with AIN-1 and AIN-2 (ALG-1 interacting protein), functional orthologs of human GW182 (11, 12) . AIN-1/2 are required for the localization of ALG-1 to processing bodies (P bodies), major cytoplasmic centers for mRNA catabolism and storage. Thus, AIN-1/2 functions as a molecular link between target-bound miRISC and downstream machinery required for translational repression and degradation of target mRNAs (11, 12) .
Activity of miRISC is facilitated by conserved cofactors that include the DEAD-box RNA helicase CGH-1 and the TRIM-NHL ubiquitin ligase NHL-2. CGH-1 and its homologs are broadly involved in regulating mRNA stability and translation during development and differentiation in both somatic and germ cells (13, 14) . In C. elegans, cgh-1 and nhl-2 are required for effective miRISC target silencing (15) . The human ortholog of CGH-1, DDX6, has been shown to promote miRISC by interaction with the CCR4-NOT deadenylase complex and mRNA degradation machinery (16) (17) (18) . The C. elegans miRISC also Significance MicroRNAs (miRNAs) are critical regulators of diverse biological processes. Despite rapid advances in understanding miRNA biogenesis and function, a gap remains in our knowledge of how miRNA effector complex activity [miRNA-induced silencing complex (miRISC)] is modulated. Specifically, the importance of posttranslational protein modifications in controlling miRISC activity remains largely unexplored. Here, we characterize a previously unidentified role for the conserved serine/threonine kinase, casein kinase II (CK2), in promoting the miRNA pathway in Caenorhabditis elegans. Notably, we establish the requirement of CK2 for miRNA function and provide mechanistic evidence that loss of CK2 compromises miRISC binding to mRNA targets. Furthermore, we identify that the miRISC cofactor and DEAD-box RNA helicase, CGH-1/DDX6, is phosphorylated by CK2 at a conserved residue, which is required for CGH-1-mediated miRNA function.
contains the fly Vasa Intronic Gene ortholog, VIG-1, and the Tudor domain protein, TSN-1, that have both been shown to be required for silencing of a let-7 target 3′UTR reporter (19) .
Posttranslational modifications (PTMs) have recently emerged as a potential mechanism for directly regulating miRISC activity (20) . To date, a limited number of studies have addressed the functional role of PTMs of miRNA pathway machinery. In particular, several PTMs to Argonaute have been characterized (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . However, little is known about the identity and functional significance PTMs in other components of miRISC.
Previously, we reported the identification of several signaling kinases, including the conserved serine/threonine kinase, casein kinase II (CK2), in a genome-wide RNAi screen for candidate factors involved in small RNA-mediated silencing in C. elegans (31, 32) . In this study, we characterize the role of CK2 as a positive regulator of miRISC activity in C. elegans. We provide evidence that CK2 functions downstream of miRNA biogenesis and is necessary for efficient miRISC binding to target mRNAs. Furthermore, we demonstrate that CK2 is required for phosphorylation of the miRISC cofactor CGH-1, which was previously implicated in facilitating miRISC-target interactions (15) . Our data indicate that CK2 phosphorylation of CGH-1 at a conserved serine residue within an N-terminal CK2 motif is required for CGH-1 function in developmental pathways regulated by miRNAs.
Results
The CK2 holoenzyme consists of two catalytic α subunits and two regulatory β subunits in a tetrameric α2β2 configuration (33) . In C. elegans, kin-3 and kin-10 encode the catalytic and regulatory subunits of CK2, respectively (34) . In addition to identifying kin-10 in a genome-wide screen for factors required for RNAi (31), we identified both CK2 subunits among factors that coimmunopurified with the GW182 homolog, AIN-1, by liquid chromatography coupled with tandem mass spectrometry. In addition to other core miRISC factors (ALG-1, ALG-2, and CGH-1), we recovered one KIN-3 peptide (KVLGTDELYEYIARY; 3.6% sequence coverage) and two KIN-10 peptides (RGNEFFCEVDEEYIQDRF and RFNLTGLNEQVPKY; 12% sequence coverage) that were absent in proteins immunopurified from the ain-1(tm3681) mutant (SI Appendix, Table S1 ), suggesting that CK2 physically interacts with miRISC. The first miRNAs were characterized as factors with altered timing of specific developmental events, including hypodermal remodeling (1, 2) . During postembryonic development, C. elegans proceeds through four larval stages (L1-L4) before emerging as an adult. Loss of core miRISC factors results in reiteration of larval developmental patterns and failure or delay in the initiation of adult-specific programs. To investigate if CK2 regulates the miRNA pathway, we first analyzed animals depleted of kin-3 or kin-10 for phenotypes associated with compromised miRISC function in the hypodermis. Because CK2 is essential for viability, we used kin-3 and kin-10 RNAi (hereafter referred to as CK2 RNAi) to attenuate its expression (SI Appendix, Fig. S1 A and B) . The formation of cuticle protrusions, termed alae, along the left and right sides of the adult animal requires the let-7 family of miRNAs (1, 35) . To investigate whether CK2 was required for the proper formation of adult alae, we compared alae formation in animals fed kin-3 and kin-10 RNAi to empty vector control RNAi. Whereas wild-type animals on empty vector control RNAi display no alae defects, RNAi of CK2 results in penetrant adult alae defects similar to those observed in RNAi of alg-1, which encodes the primary Argonaute protein in miRISC (Fig. 1A) . Similarly, seam cells are generated through stem-cell-like divisions during larval transitions, terminally differentiating in the adult to yield 16 laterally distributed seam cells on each side of the body (36) that can be visualized using a seam-cell-specific GFP reporter (37 (Fig. 1B) . These data indicate that CK2 is required for appropriate seam cell differentiation. Finally, we examined the timing of expression of a GFP reporter for the adult-specific collagen, COL-19, whose expression is controlled by miRNAs that regulate the heterochronic pathway (38, 39) . Whereas ≤5% of animals on empty vector control RNAi fail to express Pcol-19::gfp expression at three separate time points during adulthood, 20-35% of adult animals on CK2 RNAi consistently lack GFP reporter expression even at the terminal gravid adult stage examined, which is comparable to depletion of the core miRISC factor ain-1 (SI Appendix, Fig. S2A ). Taken together, these results indicate that loss of CK2 phenocopies loss of miRISC components, which suggests CK2 facilitates miRNA-mediated adult hypodermal remodeling during the larval-to-adult transition.
CK2 Promotes let-7 miRNA Family and miRISC Function. To further define the role of CK2 in the miRNA pathway, we examined genetic interactions between CK2 and let-7 family miRNAs and miRISC components. Mild phenotypes elicited by hypomorphic mutations in miRNA pathway genes create sensitized genetic backgrounds that can be enhanced by mutations in other genes required for the pathway. Therefore, we examined whether loss of kin-3 or kin-10 could enhance phenotypes associated with hypomorphic mutations in genes of the miRNA pathway.
In the transition period between each larval stage, C. elegans proceed through a quiescent state called lethargus, where animals cease pharyngeal pumping and reduce locomotion before molting. In retarded heterochronic mutants, lethargus is reiterated at the adult stage (1, 35, 40) . A mutant for mir-48, a member of the let-7 family of miRNAs, exhibits a low level of adult lethargus that is exacerbated by deleting its paralog, mir-84 (35) (Fig. 1C) . In the mir-48(n4097) sensitized genetic background, adult lethargus is significantly enhanced by CK2 RNAi at levels comparable to RNAi of miRISC components (Fig. 1C) . CK2 RNAi did not affect lethargus in wild-type animals (SI Appendix, Table S2 ). Likewise, loss of let-7 activity leads to a rupturing (Rup) phenotype, in which animals herniate through the vulva and subsequently die (1) . Two hypomorphic let-7 alleles (mg279 and n2853) exhibit a mild Rup phenotype, which is enhanced by CK2 RNAi at levels comparable to RNAi of miRISC components (Fig. 1D) . let-7 family mutants, mir-48(n4097) and the mir-48(n4097); mir-84(n4037) double mutant (35) , as well as core miRISC factor mutants, alg-1(tm369) and ain-1(ku322) (9, 12) also display Rup phenotypes that are exacerbated by CK2 RNAi (Fig. 1D ). Together these data suggest loss of CK2 enhances mutant phenotypes of the let-7 family of miRNAs.
To rule out the possibility of off-target effects of RNAi, we confirmed enhancement of let-7 mutant phenotypes in kin-10 deletion mutants. CK2 is essential for C. elegans development: kin-3 (−/−) null mutants arrest as L3 larvae and kin-10 (−/−) as L4 larvae. Consequently, CK2 null mutants are maintained in a genetically balanced background. Because the Rup phenotype can only be assessed in animals that reach the L4 stage, we examined two deletion mutants of kin-10 (ok1751 and ok2031) in the sensitized let-7(mg279) background. Consistent with results using kin-10 RNAi, we observe an enhanced Rup phenotype in kin-10 (−/−) relative to the balanced kin-10 (+/−) siblings for both kin-10 alleles (Fig. 1E) . Importantly, these data indicate that kin-10 genetic mutants recapitulate kin-10 RNAi phenotypes.
Rup phenotypes of let-7 family mutants can be partially suppressed by concurrent depletion of their mRNA targets (35, 41) .
Consistent with the hypothesis that CK2 promotes miRISCmediated target silencing, Rup enhancement by CK2 RNAi in the let-7 and miR-48 mutants is suppressed by hypomorphic mutations in their respective targets, lin-41 and hbl-1 (Fig. 1 F and G). miR-84 also regulates vulval precursor cell (VPC) fate specification by attenuating the expression of its target let-60/ RAS (42, 43) . Failure to repress LET-60 activity in specific VPCs leads to vulval cell misspecification and a multivulva phenotype (Muv) (42) . CK2 RNAi enhances Muv in a mild gainof-function let-60(ga89) allele (44) (Fig. 1H ). Taken together, these data indicate that CK2 genetically interacts with the let-7 family of miRNAs to promote miRISC function in a targetdependent manner. Because CK2 is broadly expressed (SI Appendix, Fig. S2B ), we tested whether it is required for the function of non-let-7 family miRNAs. The miRNA lsy-6 functions to specify the fate of ASEL, one of two morphologically similar, bilaterally symmetric ASE neurons (ASEL and ASER), which can be monitored by expression of an ASEL-specific Plim-6::gfp reporter (45) . Because many neurons in C. elegans are refractory to RNAi (46), we performed RNAi experiments in an nre-1 mutant background, which potentiates RNAi-mediated gene silencing in neurons (47) . CK2 RNAi enhances the penetrance of ASEL misspecification in the lsy-6(ot150) hypomorph (48) extent as alg-1 RNAi (Fig. 1I) , indicating that CK2 promotes lsy-6 function. The miR-35 family of miRNAs (miR-35-42) is expressed during embryogenesis and functions redundantly to control embryonic development (49) . Deletion of mir-35-41 leads to semipenetrant, temperature-sensitive late embryonic lethality (49) . At the permissive temperature (15°C), ∼10% of embryos display this phenotype, whereas the remaining 90% develop normally. Depletion of CK2 or the gene encoding the core miRISC factor nhl-2 significantly increases embryonic lethality, consistent with the requirement of CK2 for the function of the miR-35 family of miRNAs (Fig. 1J) . In contrast, loss of CK2 does not enhance the low level of embryonic lethality in wild-type animals (SI Appendix, Table S3 ). Collectively, our results are consistent with CK2 broadly promoting miRNA function to mediate a range of biological processes in multiple C. elegans tissues.
CK2 Is Required for miRNA Target Silencing. Because KIN-3 and KIN-10 depletion enhances multiple miRNA mutant phenotypes, we sought to determine whether these CK2-dependent physiological defects could be explained by miRNA target derepression. We examined the endogenous, developmentally regulated targets of both let-7 family and lin-4 miRNAs ( Fig.  2A) . In C. elegans, let-7 triggers the rapid degradation of lin-41 mRNA at the L4-to-adult transition (50, 51) . lin-41 encodes a TRIM/RBCC family protein, homologous to human TRIM71 (52) , that negatively regulates expression of LIN-29, a transcription factor required for adult cell fate specification (50) . Depletion of alg-1 leads to significant derepression of lin-41 mRNA compared with empty vector RNAi (Fig. 2B) . Similarly, knockdown of CK2 also significantly derepresses lin-41 levels by 1.5-to 2-fold (Fig. 2B , Left). Significant derepression is also observed for the let-7 family target, daf-12, which encodes a nuclear steroid hormone receptor that integrates environmental signals and developmental timing (51, 53) (Fig. 2B, Right) .
To determine whether derepression of target mRNAs by CK2 RNAi results in elevated target mRNA translation, we examined endogenous protein levels of LIN-14 upon CK2 RNAi. The early-acting heterochronic miRNA, lin-4, targets and silences lin-14 mRNA during the L1-to-L2 larval transition (2, 54) , resulting in a commensurate decrease in LIN-14 protein. In animals fed empty vector control RNAi, the LIN-14 protein is robustly expressed during the L1 stage (4 h) and dramatically decreases by the L2 stage (Fig. 2C, 20 h) . In contrast, when animals are subjected to CK2 RNAi, LIN-14 levels remain high during the L1-to-L2 transition to a similar degree as, or possibly higher than, animals on alg-1 RNAi (Fig.  2C, 16 -to 20-h time points). The elevated LIN-14 expression is not due to any dramatic developmental delay caused by CK2 or alg-1 RNAi during this time frame based on measurements of animal growth (SI Appendix, Fig. S3 ).
Next we examined miR-1-dependent silencing of mef-2, which encodes a muscle-specific transcription factor (55), using a 3′ UTR GFP reporter driven by the muscle-specific myo-3 promoter (Fig. 2D) . Image analysis suggests that depletion of kin-3, kin-10, or alg-1 significantly increases the intensity of mef-2 reporter expression compared with empty vector RNAi (Fig. 2 D and E) . To test the miR-1 dependence of target reporter expression, we scrambled the two miR-1 binding sites in the mef-2 3′ UTR. Consistent with a miR-1-dependent effect, no significant difference in GFP expression was detected in the scrambled reporter with CK2 or alg-1 RNAi versus empty vector control (Fig. 2 D and E) . Taken together, our genetic and target expression data indicate that CK2 promotes miRNA-mediated target silencing in a wide array of tissues and developmental stages.
CK2 Is
To explore where in the miRNA pathway CK2 functions, we first investigated whether CK2 regulates the biogenesis or stability of mature miRNAs. We performed deep sequencing of small RNAs in wild-type animals treated with vector, kin-3, or kin-10 RNAi and observed no significant differences in the global levels of mature miRNAs between empty vector and CK2 RNAi (Fig. 3A and SI Appendix, Fig. S4A and Table S4 ). Furthermore, Northern blot analysis of miR-48, miR-1, and bantam miRNA family ortholog, miR-58, in wild-type and sensitized alg-1(tm369) animals confirmed that CK2 RNAi does not dramatically affect mature or precursor miRNA levels ( Fig. 3B and SI Appendix, Fig.  S4 B and C) . We also examined whether CK2 regulates the accumulation or stability of core miRISC proteins. We detect no difference by Western blot of endogenous ALG-1, AIN-1, VIG-1, TSN-1, and CGH-1 levels between empty vector and CK2 RNAi (Fig. 3C) . Together, these data indicate that CK2 functions downstream of miRNA biogenesis and is not required for stability and/or expression of individual miRISC factors.
CK2 Promotes miRISC Association with mRNA Targets. Defects in miRISC target silencing could result from compromised ability to bind mature miRNAs or mRNA targets. To determine whether CK2 is required for miRNA or target binding to miR-ISC, we performed RNA immunoprecipitation (RIP) using a strain expressing GFP::ALG-1 (56) and compared relative miRNA and target mRNA binding in CK2 RNAi versus empty vector and gfp RNAi controls (Fig. 3D) . We observed no significant differences in the levels of let-7 or miR-48 associated with miRISC upon CK2 RNAi versus empty vector control RNAi (Fig. 3E) . Importantly, the target mRNAs of these miRNAs, lin-41 and daf-12, show an approximately twofold reduction in miRISC association upon CK2 RNAi (Fig. 3F) despite their global up-regulation (Fig. 2B) . As expected, RNAi of gfp, which reduces the expression of GFP::ALG-1, exhibited significant reduction of both miRNA and target mRNA levels (Fig. 3 F and  G) . Taken together, these data indicate that CK2 promotes efficient binding of target mRNAs, but not mature miRNAs, to miRISC.
CK2 Phosphorylates miRISC Cofactor CGH-1. Given our mass spectrometry data that CK2 physically associates with miRISC, we hypothesized that CK2 promotes miRISC target binding by phosphorylating one or more miRISC cofactors. We queried a C. elegans phosphoproteome dataset (57) and found peptides phosphorylated at CK2 motifs in CGH-1 and VIG-1. Because cgh-1 loss-of-function mutants display developmental phenotypes that are easy to observe and CGH-1 has been implicated in promoting miRISC-target interactions (15), we first examined whether CK2 physically interacts with CGH-1. Endogenous KIN-3 coimmunopurified with CGH-1::GFP in lysates from C. elegans fed glp-1 RNAi to enrich the capture of interactions in somatic tissues, the major sites of miRNA-mediated gene regulation (Fig. 4A) . glp-1 encodes a C. elegans Notch family receptor (58) required for mitotic proliferation of germ cells and maintenance of germ-line stem cells (59) . glp-1 RNAi severely disrupts early germ-line development yielding adult animals that are primarily composed of somatic cells. Mass spectrometry of endogenous CGH-1 complexes confirmed the interaction of KIN-3 and additionally identified peptides corresponding to KIN-10 and other known CGH-1 interactors, including NHL-2 (SI Appendix, Table S5 ).
To establish whether CGH-1 could be phosphorylated by CK2, we performed in vitro kinase assays. CK2 phosphorylates full-length CGH-1 in a manner dependent on CK2 activity, as inhibition of CK2 by addition of the CK2 inhibitor, 4,5,6,7-tetrabromobenzotriazole (TBB), or use of a catalytically dead KIN-3 (K67M) abrogates CGH-1 phosphorylation (Fig. 4B) . (Fig. 4C) . In vitro kinase assays with short CGH-1 peptides containing each putative CK2 phosphorylation site indicate that site 1, containing serine 2 (S2), is the predominant site phosphorylated by CK2 (Fig. 4D) . Phosphoproteomic analysis by mass spectrometry of immunopurified CGH-1 recovered peptides containing phosphorylated S2 from empty vector RNAi samples, but not kin-3 RNAi samples, suggesting that site 1 is phosphorylated in vivo in a CK2-dependent manner (SI Appendix, Table S6 ). Whereas S2 is not located in any functionally annotated domain of CGH-1, it is within an N-terminal intrinsically disordered region (60) that is conserved in DDX6 (SI Appendix, Fig. S5 ). Intrinsically disordered regions have been hypothesized to be subject to posttranslational modifications by kinases and phosphatases, which may regulate protein function (25, 61) . In addition, serine 2 of CGH-1 is broadly conserved in orthologous proteins and conservation of phosphorylation at this site is supported by large-scale phosphoproteomic evidence in amphibians and mammals (62, 63) . RNAi of kin-3, kin-10, and alg-1 all significantly increase GFP signal of the wild-type reporter versus vector (P < 0.05, mean and SD plotted, n > 10), but not the scrambled reporter (P ≥ 0.60).
CGH-1 harbors four sites matching the CK2 consensus phosphorylation motif ([S/T]-X-X-[D/E])
promote miRISC activity, then CGH-1 phosphorylation mutants should have altered miRISC function. To test this hypothesis, we generated multicopy CGH-1::GFP transgenic lines with phosphodefective (S2A) and phosphomimic (S2D/E) mutations (hereafter referred to as S2 variants). Multiple S2 variant lines were generated. Those with the most similar expression to wild-type cgh-1::gfp were selected for genetic analysis (SI Appendix, Fig. S6 ). Two phosphodefective lines are shown: S2A-2 has somatic expression levels most similar to the wild-type transgene (S2), whereas S2A-1 has substantially lower expression (SI Appendix, Fig. S6A ). The phosphomimic S2D and S2E lines express at similar levels, which are slightly higher than the wild-type transgene (S2) (SI Appendix, Fig. S6A ). Because cgh-1 is critical in germ-line development and multicopy transgenes are commonly silenced in the C. elegans germ line, we examined the function of the S2 variants in the sensitized let-7(mg279) background using a temperature-sensitive cgh-1 point mutant, cgh-1(tn691), which phenocopies cgh-1 loss of function at the nonpermissive temperature of 25°C (64) . Alone, cgh-1(tn691); let-7(mg279) displays a partially penetrant protruding vulva phenotype (Pvul) that is significantly rescued by wild-type CGH-1::GFP expression (Fig. 4 E and F) . Interestingly both phosphodefective lines significantly exacerbate Pvul despite the substantially lower expression of S2A-1 versus the wild-type trasngene (Fig. 4 E and F) . Phosphomimics yielded fewer conclusive data: S2D mutants have a phenotype similar to the nontransgenic control, whereas S2E mutants show partial, but significant, rescue. We also examined the effect of the S2 variants on the retarded alae phenotype of cgh-1(tn691); let-7(mg279) mutants. Expression of wild-type and S2E CGH-1:: GFP significantly rescues alae defects, whereas the phosphodefective S2A mutants and the S2D mutant have defects similar to, or greater than, the nontransgenic control (Fig. 4G) . Thus, in two different tissues, the CGH-1 phosphodefective S2A mutation fails to complement miRNA mutant phenotypes. Based on the robust phenotype of the S2A mutants, we hypothesize that differential results with S2D and S2E may be attributed to incomplete phosphomimicry by the substituted amino acids. Together, these data support the hypothesis that phosphorylation at S2 is important for miRNA-dependent CGH-1 function.
To determine the requirement for CK2 and phosphorylation of CGH-1 in a biological context where miRNA activity is modulated, we compared continuous development to postdauer development. Continuous development from L1 to adulthood occurs in favorable environmental conditions. By contrast, adverse conditions promote entry into the stress-resistant and developmentally arrested dauer larval stage immediately after the L2 molt (65) . If dauer larvae encounter an environment suitable for growth, they resume normal development such that postdauer cell divisions are identical to those occurring during continuous development (66, 67) . Robustness to developmental interruption by dauer is due, in part, to enhanced activity of lin-4 and let-7 family miRNAs, such that lin-4 can substitute for miR-48, miR-241, and miR-84 during postdauer development but not continuous development (68) . Surprisingly, enhancement of miRNA activity occurs without alg-1, as heterochronic phenotypes of alg-1 mutants are efficiently suppressed postdauer (68) . This suggests that modulatory proteins elevate the activity of the remaining ALG-2-containing miRISC. CK2 appears to contribute to this phenomenon, as kin-3 RNAi significantly reduces postdauer suppression of alg-1(gk214) alae defects (SI Appendix, Fig. S7A ). Interestingly, we observe that during postdauer development, the retarded alae phenotype of S2A mutants is significantly suppressed, suggesting that CK2 modification of CGH-1 is dispensable during postdauer development (SI Appendix, Fig. S7B ).
Discussion
Here we report that subunits encoding the C. elegans casein kinase II, kin-3 and kin-10, are required for effective activity of the miRNA pathway. Genetically, our analyses suggest that kin-3 and kin-10 promote the function of several miRNA/miRNA families that regulate diverse processes, including the conserved function of the let-7 family of miRNAs in the control of animal development and cellular differentiation. Mechanistically, our analyses place CK2 function at the step of miRISC association with mRNA targets, downstream of miRNA biogenesis and loading into miRISC. Molecular assays indicate that CK2 subunits are required for target silencing and that their depletion compromises miRISC binding to let-7 target mRNAs. Through the use of proteomic and in vitro methods, we establish the conserved miRISC cofactor, CGH-1, as a direct CK2 substrate at a conserved N-terminal serine residue (S2). Additional genetic GST-tagged CGH-1 peptides composed of 20 residues flanking each putative CK2 phosphorylation site were incubated in vitro with CK2 and analyzed by SDS/PAGE and autoradiography. 32 P, autoradiogram; CB, Coomassie Blue stained gel. (E and F ) Genetic analysis of CGH-1 serine 2 (S2) phosphovariants in cgh-1(tn691)ts; let-7(mg279) suggests phosphorylation of CGH-1 at S2 promotes miRISC function (E) Representative images of Protruding vulva (Pvul). Adult vulva indicated by arrow (120 h post-L1, 25°C). (F) Quantitation of Pvul. Compared with cgh-1(tn691)ts; let-7(mg279) with no transgene the cgh-1::gfp (S2) transgene significantly rescues Pvul. S2A mutants (lines 1 and 2) significantly enhance Pvul (two-tailed Fisher's exact test *P < 0.0001 for S2 variants versus "no TG," mean and SD plotted for three technical replicates within a single experiment, n ≥ 95). (G) S2 and S2E significantly rescue alae defects of cgh-1(tn691)ts; let-7(mg279). S2A mutants significantly enhance (line 1) or have no significant effect (line 2) on defects (two-tailed Fisher's exact test *P < 0.0001 for S2 variants versus "no TG"). TG, transgene; S2A lines 1 and 2, phosphodefective Ser-to-Ala mutation; S2D/E, phosphomimic Ser-to-Asp/Glu mutations.
analyses suggest that S2 is important for miRNA-dependent CGH-1 function in the let-7 pathway. Because CGH-1 is part of a family of DEAD-box RNA helicases that influence all permutations of protein-protein, protein-RNA, and RNA-RNA interactions, we propose that phosphorylation of CGH-1 by CK2 may influence miRISC target binding by (i) directly promoting miRISC interaction with targets, either by promoting CGH-1 association with miRISC or by altering affinity of a CGH-1-associated miRISC for targets, and/or (ii) promoting CGH-1 association with factors involved with mRNA translation and decay. Biochemically, phosphorylation in the N-terminal disordered region of CGH-1 may affect these changes by triggering a conformational change that alters the intrinsic activity of CGH-1 or facilitates its association with other factors.
Intriguingly, our analysis of postdauer development suggests that CK2 function in the C. elegans miRNA pathway is different from that during continuous development. Postdauer suppression of miRNA phenotypes requires CK2, but not CK2 phosphorylation of CGH-1 (SI Appendix, Fig. S7B ), suggesting that during postdauer development, CK2 may have alternative miRNA pathway substrates. Alternatively, additional factors may dictate CK2 specificity during continuous development versus postdauer development. Despite considerable efforts, the matter of whether CK2 is constitutively active or activated by specific signals remains controversial (69) . Therefore, further investigation into CK2 function in the miRNA pathway during postdauer development may prove a useful system for extending our understanding of the regulation of CK2. As modulating miRNA activity is crucial for development and disease, dissecting the mechanisms that activate or antagonize CK2 activity in the miRNA pathway may also provide further insights into how the miRNA pathway is regulated.
Ribonucleoprotein (RNP) granules, such as germ-line P granules and the miRISC-resident P bodies in somatic tissues, possess hydrogel-like properties (70, 71) whose dynamics of formation and dissolution depend, in part, on the phosphorylation of granule components. RNA binding proteins within these granules typically contain low complexity sequences at their N and C termini that form disordered domains (72) . These regions are often sites for phosphorylation and other posttranslational modifications that trigger or inhibit the phase transition properties of RNA-binding proteins (73) (74) (75) (76) . Interestingly, the CK2 phosphorylation site on CGH-1 (and human DDX6) resides within a prominent disordered region in its N terminus. Furthermore, a recent study of germ-line P granules demonstrated that inactivation of CGH-1 in the germ line causes a profound transformation of P granules from a hydrogel-like state to a striking, rigid square-shaped matrix (70) . Thus, we speculate that CK2-mediated phosphorylation of CGH-1 in somatic tissues, the predominant sites of miRNA-mediated gene regulation, may promote CGH-1 recruitment to miRISC-resident P bodies and possibly affect the recruitment of other cofactors to miRISC RNP granules.
Materials and Methods
Detailed methods are available in SI Appendix, Supplemental Materials and Methods.
C. elegans Strains and Plasmids. All strains used in this study are listed in SI Appendix, Table S7 . C. elegans were grown and maintained under standard laboratory conditions (77) and synchronized by hypochlorite treatment and overnight hatching in M9 buffer, except where indicated. Descriptions of plasmid construction and generation of transgenic animals are described in SI Appendix, Supplemental Materials and Methods.
RNAi. All RNAi clones are from the Ahringer RNAi library (78) , except the kin-3 RNAi clone, which is from the C. elegans ORFeome RNAi library (79) , and the cgh-1 3′ UTR RNAi clone (pJK301), which was made for this study. Standard feeding RNAi procedures (80) were followed. Specific modifications to RNAi conditions, including duration, strength, and temperature, are detailed in SI Appendix, Supplemental Materials and Methods.
Pcol-19::gfp Phenotyping. The relative number of animals expressing GFP were tracked from young to gravid adulthood by scoring the number of animals expressing GFP at 60 h, 72 h, and 80 h post-L1 at 20°C. mef-2 Reporter Image Analysis. Images were captured on an Olympus BX61 epifluorescence compound microscope with a Hamamatsu ORCA-ER camera using Slidebook 4.0.1 digital microscopy software (Intelligent Imaging Innovations) and processed in ImageJ with custom scripts.
Dauer Induction and Postdauer Phenotyping. Dauer induction was achieved using crude dauer pheromone (81) for kin-3 RNAi experiments and by starvation/crowding for experiments with cgh-1(tn691); let-7(mg279). All strains were maintained at 20°C. Strains in the cgh-1(tn691); let-7(mg279) background were shifted to 25°C at the L2 molt during continuous development or after selection of dauer larvae for postdauer development. Additional phenotyping details are provided in SI Appendix, Supplemental Materials and Methods.
CK2 in Vitro Kinase Assays. Recombinant GST fusion proteins were generated and isolated from Escherichia coli (82) . Purified recombinant proteins were analyzed by SDS/PAGE and Coomassie Blue to determine protein concentrations by comparison with BSA standards. For in vitro kinase reactions, 1 μg of recombinant CGH-1 was mixed with 500 nM recombinant KIN-3 (either WT or K67M mutant), 500 nM KIN-10, 4 μCi of 32 P γATP, and 200 μM cold ATP in 20 mM Tris·HCl, pH 7.5, 50 mM KCl, and 20 mM MgCl2. Reactions were incubated at room temperature for 30 min. To inhibit CK2 activity in vitro, TBB was added to 5 μM. To map the specific phosphorylation site on CGH-1, GST-tagged CGH-1 peptides composed of the 20 aa flanking the four putative CK2 phosphorylation sites were incubated with CK2 as described above (peptide sequences in SI Appendix, Table S8 ). All data were analyzed by SDS/PAGE and autoradiography.
Western Blotting. Protein samples from synchronized populations were prepared by direct boiling in Novex Tris-glycine SDS sample buffer (Invitrogen), supplemented with 0.1 M DTT, resolved on Novex Tris-glycine gels (Invitrogen), and immobilized on Immobilon-FL transfer membrane (Millipore). Membranes were probed with custom rabbit polyclonal antibodies to ALG-1 (1:1,000), AIN-1 (1:1,000), CGH-1 (1:1,000), GFP (1:500), KIN-3 (1:500), TSN-1 (1:1,000), and VIG-1 (1:1,000), or γ-tubulin (Sigma LL-17) (1:2,000). Peroxidase-AffiniPure goat anti-rabbit IgG secondary antibody was used at 1:10,000 (Jackson ImmunoResearch Laboratories) for detection using Pierce ECL Western blotting substrate (Thermo Scientific).
Antibody Production. Custom polyclonal antibodies to C. elegans proteins were generated by immunizing rabbits with synthetic antigenic peptides conjugated to KLH (Proteintech). Antigenic peptide sequences are listed in SI Appendix, Table S8 . Antibody to GFP was made using recombinant GFP purified from E. coli. The LIN-14 antibody was a gift from Gary Ruvkun, Department of Molecular Biology, Massachusetts General Hospital, Boston (83) .
Immunoprecipitation and Mass Spectrometry. Synchronized populations were frozen in liquid nitrogen and homogenized with a Mixer Mill MM 400 ball mill homogenizer (Retsch). Immunoprecipitations from homogenates were performed using guidelines described (84) . AIN-1 mass spectrometry was performed, in duplicate, on complexes isolated using a housemade AIN-1 antibody in gravid wild-type (N2) and ain-1(tm3681) samples. CGH-1 mass spectrometry was performed on complexes isolated using an endogenous CGH-1 antibody in L3 and adult wild-type (N2) worms. CGH-1 phosphoproteomic analysis by mass spectrometry was performed on complexes isolated using an endogenous CGH-1 antibody in empty vector and kin-3 RNAitreated adult worms. Protein identification by mass spectrometry was performed as described (85) . Additional details are provided in SI Appendix, Supplemental Materials and Methods.
RNA Analyses. Samples were collected from synchronized populations at the following times: 48 h post-L1 for mature miRNA, 44 h post-L1 for lin-41 mRNA, and 40 h post-L1 daf-12 mRNA. Biological replicates for let-7 target analysis indicate at least two samples for which animal collection, RNA extraction, and qPCR analysis were conducted independently. Conditions for kin-3, kin-10, and alg-1 RNAi are described in SI Appendix, Supplemental Materials and Methods, Modified RNAi Conditions. Total RNA isolation was conducted as described (86) . For miRNA analysis: (i) Northern blotting was performed as described (87) using 1.5 μg total RNA and Starfire DNA probes (IDT) (SI Appendix, Table S8 ), and (ii) RT-qPCR analysis was conducted using miRNA TaqMan assays and probes (hsa-let-7a, cat. no. 4427975; cel-miR-48, cat. no. 4427975; and U18, cat. no. 4427975) (Applied Biosystems) as described (86) . For mRNA analysis, cDNA was synthesized from total RNA using the Multiscribe Reverse Transcriptase Kit (Applied Biosystems). Specific mRNAs were analyzed by RT-qPCR using Power SYBR Green Master Mix 2X (Applied Biosystems). Relative miRNA and mRNA levels were calculated based on the ΔΔ2Ct method (88) using U18 and eft-2 for normalization, respectively. RT-qPCR primer sequences and Starfire Probes are listed in SI Appendix, Table S8 ).
RIP. GFP-ALG-1 was immunoprecipitated from L4 stage (48 h post-L1) CT20 with 3E6 anti-GFP antibody (Invitrogen). For each RIP, antibody was crosslinked to Protein A Dynabeads (Invitrogen) and incubated at 4°C for 1 h with homogenized sample. Beads were washed with RIP wash buffer (50 mM Tris·HCl pH 7.5, 200 mM KCl, 0.05% Nonidet P-40), then split for protein and RNA analyses. For protein analyses, SDS sample buffer (Novex Tris-glycine; Invitrogen), was added directly to beads and incubated at 50°C for 10 min. Eluted proteins were supplemented with 0.1 M DTT and incubated at 90°C for 5 min before Western blotting. For RNA analysis, 1 mL of TRI-Reagent (Ambion) and 10 ng of Firefly Luciferase RNA (Promega) were directly added to beads and extracted as described in "RNA Analyses," with extended RNA precipitation for 2 h at −30°C. cDNA and miRNA taqmans were synthesized and analyzed as described in "RNA Analyses." RT-qPCR analyses were normalized to Firefly Luciferase.
Small RNA Sequencing and miRNA Analysis. Samples were collected from synchronized populations of 48 h postarrested L1 fed L4440, kin-3, or kin-10
RNAi. Total RNA was isolated as described in the "RNA Analyses" section. Total RNA was submitted to the Beijing Genomics Institute (BGI) for deep sequencing. Sequencing reads were processed to remove low-quality reads and trim artificial adapter sequences following BGI protocols. Briefly, reads were marked and removed for low quality if they had (i) more than four bases whose quality score was lower than 10 or (ii) more than six bases whose quality score was lower than 13. The 3′ adapter sequences were then trimmed from the remaining high-quality reads. Finally, reads were removed if they (i) lacked a 3′ adapter sequence, (ii) were 5′-3′ adapter ligation products, (iii) were 5′-5′ adapter ligation products, (iv) were shorter than 18 nt, or (v) contained only As (homopolymers). High-quality reads were aligned to the reference C. elegans genome version WS220 using Bowtie2 (89) with the following parameters: -f -N 0 -M 10. Reads that aligned with zero mismatches to one genomic locus were annotated to mature miRNA coordinates from miRBase Release 19 (4) . Mature miRNA read counts in each library were normalized to the number of mapped reads in the library; mature miRNA abundance is reported as reads per million (RPM) mapped reads (SI Appendix, Table S4 ). Raw sequence data are available through the NCBI's Gene Expression Omnibus using accession GSE66764.
